Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 27, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

February 28, 2025

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DEVICE

Endovascular denervation System (Generator and Catheter )

All patients receive endovascular denervation (EDN) treatment

Trial Locations (1)

Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors

lead

Shanghai Golden Leaf MedTec Co. Ltd

INDUSTRY